Evotec SE (EVO) EBT (2009 - 2025)

Evotec SE has disclosed EBT across 9 years of filings, most recently posting -$50.5 million for Q4 2025.

• In Q4 2025, EBT rose 54.72% year-over-year to -$50.5 million; the TTM figure through Dec 2025 stood at -$163.6 million (up 46.33% YoY), while the FY2025 annual figure was -$98.0 million, up 53.31% from the prior year.
• EBT came in at -$50.5 million for Q4 2025 at Evotec SE, down from -$50.2 million in the prior quarter.
• In the past five years, EBT ranged from a high of $165.6 million in Q3 2021 to a low of -$296.3 million in Q4 2022.
• Average EBT over 5 years is -$32.7 million, with a median of -$30.2 million recorded in 2025.
• Year-over-year, EBT soared 1784.32% in 2021 and tumbled 1352.03% in 2022.
• Over 5 years, EBT stood at -$20.4 million in 2021, then plunged by 1352.03% to -$296.3 million in 2022, then surged by 91.28% to -$25.8 million in 2023, then plunged by 331.81% to -$111.6 million in 2024, then surged by 54.72% to -$50.5 million in 2025.
• Per Business Quant data, the three most recent EBT figures were -$50.5 million in Q4 2025, -$50.2 million in Q3 2025, and -$31.4 million in Q2 2025.